High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI (Q46623880)
Jump to navigation
Jump to search
scientific article published on 19 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI |
scientific article published on 19 February 2008 |
Statements
High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis (English)
Christopher P Cannon
Sabina A Murphy
Marc J Schweiger
Gregory R Giugliano
TIMI 22 Investigators